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Distal vascular control during lower extremity
arterial reconstruction can be problematic. Vascular
clamps, silicone rubber vessel loops, flow arresters,
and intraluminal balloon catheters are commonly
used methods to secure vascular control. These
devices may result in poor control with calcified ves-
sels, may cause local intimal injury to the vessel, and
may hinder suturing by cluttering the field and
obstructing the view. Often the target vessel is small
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Purpose: The purpose of this study was to evaluate the role and efficacy of the tourni-
quet in lower limb revascularization.
Methods: During a 3-year period, 195 patients underwent 205 infrainguinal reconstruc-
tion operations in the lower extremity. These patients underwent bypass with a tourni-
quet and inflow occlusion (group 1) or bypass without a tourniquet (group 2). The type
of infrainguinal reconstruction, tourniquet ischemia time, blood loss, and complications
related to tourniquet use were recorded. A subset of patients underwent serial muscle
biopsies. Specimens from calf muscle were taken just (1) before application of the
tourniquet, (2) before tourniquet release, and (3) once wound closure was initiated.
These biopsy specimens were studied by histochemical staining and also analyzed for
phosphorylase enzyme, a marker for subcellular ischemia.
Results: One hundred eleven patients underwent 117 infrainguinal reconstruction proce-
dures in which the tourniquet and inflow occlusion were used. These patients were
matched against 84 patients who underwent 88 infrainguinal reconstructions without the
use of the tourniquet. Complete hemostatic control in group 1 was obtained in 108 of the
procedures (92%). Eight percent of the procedures required minor additional techniques
to obtain complete hemostasis; in two instances, the tourniquet was removed because it
did not provide hemostasis. Mean tourniquet time was less than 1 hour for all recon-
struction groups. There were no instances of neurologic deficit, thrombosis of distal ves-
sels, or vascular injury that was related to the use of a tourniquet. A comparison of the
two groups revealed no differences with regard to overall blood loss (P = .63) or duration
of operation (P = 0.60), observations that reflect the complexity of the cases rather than
the use or nonuse of a tourniquet. When tourniquet control was used, we noted a definite
decrease in the time for the distal dissection, because total vascular control with extensive
dissection was unnecessary. Histochemical analysis with phosphorylase revealed a conver-
sion of tissue with active enzyme activity to a low level with tourniquet use (P < .05).
Conclusion: The use of a tourniquet for lower limb revascularization is safe and effective
and improves visualization of the operative field. Less dissection of the target vessels is
required. With a combination of the nonuse of clamps and other occluding devices, we
project a decrease in host hyperplastic response that will, in turn, impact favorably on
patency rates. The possibility exists that early failure may be prevented by avoiding the
application of traumatic forces to diseased and brittle or calcified arteries. In this study,
tourniquet time had no impact on overall operative procedural time, although certain
phases of the operation were clearly shortened and facilitated, particularly in complex
and difficult reconstructions. Histochemical changes found in muscle biopsy specimens
did not adversely impact patients clinically, but further investigation is required to elu-
cidate subcellular events. (J Vasc Surg 2000;31:436-42.)
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and calcified, resulting in poor vascular control. The
use of tourniquets has been reported in the vascular
surgical literature; but despite the advantages of lim-
iting distal dissection, avoiding excessive target ves-
sel trauma, and improving exposure of the operative
field, its use has not gained universal acceptance.
Critics have voiced concern about poor control
when calcification of arteries is present and have
warned of tissue ischemia with subsequent morbidi-
ty.1,2 We have added the simple modification of
inflow occlusion in our use of the tourniquet and
have studied additionally the impact of tourniquet
ischemia and ischemia/reperfusion with the use of
histologic and histochemical analysis.
METHODS 
Between July 1996 and July 1999, we performed
205 infrainguinal bypass procedures in 195 patients.
In group 1, we used inflow occlusion and tourniquet
compression; patients in group 2 underwent standard
methods of vascular control, which included clamps
and occasionally intraluminal occluding devices. Table
I describes the subsets of the entire series and the
demographics and incidence of critical risk factors. All
these procedures were performed consecutively, but
the tourniquet procedures were performed by two of
the authors (HD, KW); control nontourniquet proce-
dures were performed by two other members of our
team (FS, FW). The numbers of patients who under-
went specific types of bypass procedures in relationship
to indications are summarized in Table II. For group
1, distal dissection was performed without mobiliza-
tion of the vessel from its bed nor control of side
branches. Only enough of the vessel was exposed to
perform the anastomosis. Proximal inflow control,
which established tunnels and conduit preparation,
were then performed in the standard manner.
Systemic heparinization (70 units/kg) was instituted,
and a padded pneumatic tourniquet was placed on the
thigh. If an in situ vein graft procedure is being per-
formed, then the proximal anastomosis is completed
at this stage. For reversed saphenous veins or if a pros-
thetic (such as the umbilical vein graft) is used, the dis-
tal anastomosis is performed first.
Before the distal anastomosis is begun, inflow
occlusion is initiated first to decrease arterial inflow as
venous blood is compressed from toe to thigh. The
leg is elevated, and an Esmarck bandage is wrapped
tightly from the foot to the tourniquet, which is then
inflated to 280 mm Hg. The Esmarck bandage is then
Table II. Indications for revascularization
Tourniquet (group 1) No tourniquet (group 2)
Bypass type Claudication Rest pain Gangrene Ulcer TOTAL Claudication Rest pain Gangrene Ulcer TOTAL
AK Pop 1 1 5 1 8 2 5 7 9 23
BK Pop 2 9 3 2 16 3 8 13 6 30
Crural 7 26 38 15 86 0 9 12 6 27
DP 0 1 5 1 7 1 0 5 2 8
TOTAL 10 37 51 19 117 6 22 37 23 88
AK Pop, Above-knee popliteal procedure; BK Pop, below-knee popliteal procedure; DP, dorsalis pedis.
Table I. Demographics and risk factors
Tourniquet (group 1) No tourniquet (group 2)
AK Pop BK Pop Crural DP TOTAL AK Pop BK Pop Crural DP TOTAL
Patients (n) 8 16 80 7 111 22 30 25 7 84
Mean age (y) 71 74 74 70 73 71 73 72 66 72
Gender (M:F) 1:3 1:2 1.4:1 6:1 1.1:1 1:1.2 1:1.1 2.1:1 1.3:1 1:1
Diabetes, n (%) 5 (62) 7 (43) 54 (67) 7 (100) 73 (65) 14 (64) 15 (50) 15 (60) 7 (100) 51 (60)
Hypertension, n (%) 5 (62) 9 (52) 51 (63)* 5 (71) 70 (63) 15 (68) 21 (70) 9 (36)* 4 (57) 49 (58)
Heart disease, n (%) 7 (87) 7 (43) 49 (61) 4 (29) 67 (60) 14 (63) 23 (76) 14 (56) 3 (43) 54 (64)
Renal failure, n (%) 2 (25) 2 (12) 13 (16) 0 (0) 17 (15) 4 (18) 6 (20) 7 (28) 0 (0) 17 (20)
AK Pop, Above-knee popliteal procedure; BK Pop, below-knee popliteal procedure; DP, dorsalis pedis.
*P < .05 (Crural subset, hypertension).
Table III. Type of operation
Tourniquet (group 1)
Type of conduit (n)
Bypass type n In situ GSV (%) Reversed GSV (%) UV (%) PTFE (%) TT (min) Blood loss (mL) dAVF, n (%)
AK Pop 8 0 (0) 0 (0) 8 (100) 0 (0) 31 ± 15 258 ± 97 0 (0)
BK Pop 15 3 (20) 3 (20) 9 (60) 0 (0) 39 ± 18 354 ± 268 0 (0)
Crural 92 15 (17) 15 (17) 56 (61) 1 (1) 50 ± 24 335 ± 333 44 (50)
DP 7 5 (71) 2 (29) 0 (0) 0 (0) 45 ± 18 270 ± 67 0 (0)
TT, Tourniquet time; dAVF, distal arteriovenous fistula; GSV, greater saphenous vein; UV, umbilical vein; PTFE, polytetrafluoroethylene; AK Pop, 
above-knee popliteal procedure; BK Pop, below-knee popliteal procedure; DP, dorsalis pedis.
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removed, and the anastomosis is performed. At the
completion of the anastomosis, both the tourniquet
and inflow occlusion are released. Modifications of
this technique were made for short bypass procedures
and for in situ vein bypass procedures (Fig 1). In the
case of the former, both anastomoses can be per-
formed with tourniquet control. We generally perform
the proximal anastomosis first and deflate the tourni-
quet for evaluation and tunneling if necessary. We
reapply the Esmarck bandage, reinflate the tourniquet,
remove the Esmarck bandage, and conclude by per-
forming the distal anastomosis. For in situ vein bypass
procedures or in any other case in which the proximal
anastomosis is performed first, we generally do not fill
the graft with heparin solution because the graft is
compressed and heparin is systemically administered
to the patient. The assessment of efficiency of the
tourniquet was based on visual evidence of blood loss
and ease of dissection and creating the anastomosis. 
Calf muscle biopsies were performed in 17 cases
to assess the impact of tourniquet ischemia and
reperfusion. These biopsy specimens were harvested
before tourniquet application (baseline), before
tourniquet release (ischemia), and just preceding
skin closure (reperfusion). The specimens were
placed in OCT embedding medium (Tissue Tek;
Miles Inc, Diagnostics Division, Elkhart, Ind), with
their fibers perpendicular to the surface of a piece of
cardboard and frozen in liquid nitrogen. Cross-sec-
tions, 6 µm thick, were taken from the midportion
of the tissue blocks and cut on a cryostat at –25°C.
Standard hematoxylin and eosin staining and modi-
fied Gomori trichome staining and alizarin red stain-
ing for calcium were performed on these frozen sec-
tions. Histochemical evaluation of each muscle biop-
sy specimen was also performed for intracellular
phosphorylase activity.3 Phosphorylase is the rate-
limiting enzyme in glycogenolysis, degrading glyco-
gen to glucose 6-phosphate. The histochemical
technique depends on the synthesis of polysaccha-
ride chains from glucose-1-phosphate, with the
length of unbranched chains being proportional to
phosphorylase activity. Because the color with iodine
staining varies according to the length of the chains,
high phosphorylase activity in skeletal muscle cells
will stain darker. Phosphorylase activity was mea-
sured quantitatively with the SAMBO 4000 Cell
Imaging Analysis System (IPE Imaging Products
Fig 1. Algorithm for the performance of lower limb
bypass procedures with the use of the modified tourniquet
technique. ASV-R, Autogenous saphenous vein, reversed;
ISSV, in situ saphenous vein.
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International, Inc, Chantilly, Va), which automati-
cally records three color zones: black, brown, and
yellow, which represent high, medium, and low
enzyme activity, respectively. Within a uniform spec-
imen as determined by light microscopy, five micro-
scopic areas from each muscle specimen were select-
ed randomly for quantitative measurements of phos-
phorylase activity. Comparisons were then made
between the mean values of phosphorylase activities
for baseline versus ischemia versus reperfusion spec-
imens with the Student t test.
RESULTS 
Patient demographics for each group were similar
with respect to age and gender. The incidence of the
major risk factors (diabetes mellitus, hypertension,
and coronary artery disease) was also similar (Table
I). The only statistically significant difference was for
hypertension in the crural subset. In a comparison of
both groups with respect to surgical indications, there
was also no statistically significant difference in the
incidence of gangrene, ulceration, rest pain, or clau-
dication (Table II). As a tertiary referral institution,
many of our patients have had previous reconstruc-
tions and compromised arterial outflow. This trend is
reflected in the type of operation that was performed
(that is, more crurals than popliteals and also the type
of bypass conduit used). Overall more popliteal
reconstructions were performed in group 2, and this
was counterbalanced with a significantly lower num-
ber of crural operations compared with group 1 (P <
.01). In the absence of autologous greater saphenous
vein, our choice for prosthetic was umbilical vein.
Distal arteriovenous fistulas were created in conjunc-
tion with the umbilical vein in the crural position.
The conduits that were used in this study are shown
in Table III. Also shown are the tourniquet times for
each reconstruction type of group 1.
Tourniquet inflation time ranged from 17 to 95
minutes, with an average inflation time of 52 minutes.
The lengthier cases were due to difficult anastomosis,
such as those in which dense calcification was present.
In some instances, time was increased because of dif-
ficult access to the vessels where limbs were large and
muscles more bulky. Tourniquet hemostasis was total-
ly inadequate in two cases. In seven other cases,
placement of atraumatic vascular clamps was required
in addition to the tourniquet. This was probably due
to inadequate placement of the tourniquet or, in
some instances, the inability to totally compress thigh
arteries, as often occurs in patients who are receiving
dialysis therapy. There were no complications directly
attributable to the tourniquet technique. Our early
graft patencies in this series were similar to our previ-
ously reported data in which standard means for vas-
cular control with clamps was the primary method for
securing vascular control.4,5
Operative times for uncomplicated cases ranged
between 90 and 180 minutes. These times were dou-
bled and sometimes even tripled when adjunctive pro-
cedures were used, such as the performance of an
endarterectomy with a patch or angioplasty and stent-
ing of the inflow circulation. In the crural group, time
was always increased because additional time was
required to create a distal arterial venous fistula.
Average blood loss was 342 ± 307 mL in the tourni-
quet group and 317 ± 298 mL in the conventional
clamping group, again findings that were related to
adjunctive procedures in most cases. Operative time
and blood loss differences were therefore not statisti-
cally significant between the groups. Nevertheless, in
individual cases, the most time was spent on the per-
formance of the distal anastomosis in the crural subset,
as compared with all other groups. A correlation coef-
ficient of r = 0.56 between operative time and blood
loss indicated that complex cases take longer and are
No tourniquet (group 2)
Type of conduit (n)
n In situ GSV (%) Reversed GSV (%) UV (%) PTFE (%) Blood loss (mL) dAVF, n (%)
23 0 (0) 8 (35) 11 (48) 4 (17) 277 ± 213 0 (0)
30 2 (7) 16 (53) 10 (33) 2 (7) 346 ± 464 0 (0)
27 7 (26) 16 (61) 4 (14) 0 (0) 402 ± 257 3 (12)
8 3 (37) 5 (63) 0 (0) 0 (0) 183 ± 68 0 (0)
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associated with greater blood loss, observations that
are unrelated to the tourniquet but rather to the addi-
tion of inflow and outflow procedures or the perfor-
mance of an operation in a previously operated field.
Hematoxylin and eosin staining of muscle speci-
mens revealed no gross changes in cell architecture
between the three muscle biopsy groups. No calcium
deposition or tissue necrosis was noted in any of the
specimens. Intracellular phosphorylase activity, how-
ever, revealed decreased activity in the ischemic and
reperfused specimens when compared with the base-
line specimen (Fig 2). Pretourniquet (baseline) speci-
mens were associated with areas of high enzyme activ-
ity. An inverse relationship, low enzyme activity, was
found in the ischemic and reperfusion specimens. The
baseline specimens showed that an average of 71% of
the area was associated with high enzyme activity and
a 2.5% area of low enzyme activity (Table IV). The
ischemia and the reperfusion specimens revealed high
phosphorylase activity areas of only 25.5% and 21.1%,
respectively. Conversely, low enzyme activity areas
were 44% and 49%, respectively. Both the ischemia
and reperfusion phosphorylase activities were signifi-
cantly different from baseline (P < .05).  
DISCUSSION
The use of a tourniquet as a life-saving maneuver
to stop hemorrhage is an ancient maneuver, but
despite this and its demonstrable value during
wartime,6 this modality has failed to achieve universal
acceptance for use in lower extremity revasculariza-
tion procedures. Vascular surgeons have been slow to
use this technique despite the successful application in
the fields of orthopedics, trauma, and podiatry.7-9
This may be due to not only the lack of familiarity
with the procedure but also because unfounded con-
cern for potential complications, such as compart-
ment syndrome, muscle necrosis, and nerve injury.
Scheinin and Lindfors10 first reported the use of a
thigh tourniquet for vascular reconstruction in 1979,
describing the repair of four popliteal aneurysms with
proximal tourniquet occlusion. The usefulness of
tourniquet techniques in lower limb revascularization
were also reported in 1980 by Bernhard et al,11 in
1992 by Collier,12 and in 1993 by Wagner et al.1
Because of one case that developed thrombosis and
nerve injury in the series by Bernhard et al,11 many
surgeons were reluctant to introduce this method
into their practice,2 even with the appreciation of the
fact that heparin had not been used in that case. No
similar events have been reported since, most likely
because of the universal use of heparin anticoagula-
tion before tourniquet inflation.7,13,14 Ochoa et al15
reported histologic changes in peripheral nerves con-
centrated at the edge of the tourniquet when inflated
to pressures of 500 mm Hg or 1000 mm Hg. Others,
however, showed no nerve injury with pressures of
250 mm Hg for less than 2 hours.16
Inflow occlusion combined with a tourniquet is
a simple and elegant method to secure vascular con-
trol. It can be established rapidly and enables a
bloodless field in 92% of the cases. Although the
present series describes the use of the tourniquet and
inflow occlusion for primary revascularization, this
procedure is also useful for redo cases, thromboem-
bolectomy, and graft revisions. Once exposure of the
target vessel is complete, tourniquet application
takes only several minutes, and a bloodless operative
field is easily secured. 
We experienced failure in only two cases in which
the artery to be compressed was densely calcified. In
seven other cases, oozing was controlled by the use of
atraumatic vascular clamps in addition to maintenance
of tourniquet control. Clearly, failure will occur where
the thigh vessels are incompressible, most often in
patients with end-stage renal disease. It may also be
due to faulty application of the tourniquet. We believe
that the use of inflow occlusion is a useful adjunct,
although this study does not provide a control series
to validate this point. Nonetheless, based on historic
controls, we have noted that the frequent occurrence
of residual oozing of blood in tourniquet cases can be
prevented most times by the use of inflow occlusion. 
Without clamps, vessel loops, and intraluminal
occluders, the distal anastomosis is technically easier
to perform, and sutures can be placed with exacting
Table IV. Phosphorylase activity in equivalent areas of high, medium, and low staining
Specimens (n = 17 × [3/patient])
Phosphorylase activity Baseline (area ± SEM) Ischemia (area ± SEM) Reperfusion (area ± SEM)
High (black-stained cells) 70.97 ± 9.05 25.49 ± 7.52* 21.14 ± 5.14*
Medium (brown-stained cells) 26.54 ± 8.67 30.50 ± 15.97 29.40 ± 13.35
Low (yellow-stained cells) 2.49 ± 6.59 44.01 ± 21.25* 49.45 ± 15.86*
*P < .05 vs baseline.
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Fig 2. Phosphorylase enzyme activity (brown areas) in calf muscle biopsy sections. (A) Before
tourniquet inflation. (B) Before release of the tourniquet. (C) Before skin closure. Black-
stained areas reflect high enzyme activity, although brown and yellow–stained areas reflect
medium and low enzyme activity, respectively. Note the significant decrease in activity in the
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precision. In most cases, the recipient artery tends to
“fall open” after the arteriotomy is performed
because there is no distortion of the vessel or com-
pression by adjacent clamps. The only exception is
with a densely calcified artery. Another major advan-
tage in the use of a tourniquet is that complete dis-
section of vessels from their bed or controlling side
branches is unnecessary. Operative time for this phase
of the operation is reduced, and potential trauma is
obviated. This is especially helpful in the creation of a
distal arteriovenous fistula.5 The artery and the
accompanying vein can be left undisturbed in its bed,
except for the clearance of the anterior surface of
these vessels. This makes the entire procedure much
simpler. Time for performing the anastomosis is com-
parable for both groups, approximately 20 minutes
for popliteal anastomosis and 50 minutes for crural
reconstructions in which distal arteriovenous fistulas
are also constructed. The real time savings comes with
the dissection of these vessels because total control is
unnecessary, which means that branches of arteries or
veins do not have to be dissected and loops are often
not required to secure the target vessels. It is also pos-
sible, as some authors have reported,17-19 that paten-
cy rates might improve because of reduced distal anas-
tomotic intimal hyperplasia.
There were no morphologic changes (such as cal-
cium deposition) that would indicate tissue necrosis
on the muscle sections stained with hematoxylin,
eosin, and Gomori stains. Histologic study of the
muscle biopsy specimens with these stains also did not
show any pathologic changes for any of the samples
examined. On the other hand, the phosphorylase
enzyme histochemical analysis did show decreased
phosphorylase in the ischemia and reperfusion muscle
specimens. Clearly, there was a metabolic deteriora-
tion within the skeletal muscle cell; but despite this
difference, there was no clinical evidence for an
adverse outcome in any patient.
CONCLUSION
We have concluded that the tourniquet enhances
the performance of lower limb revascularization and
should be used for all cases. The tourniquet produces
a bloodless operative field and avoids clamp trauma
and vessel distortion. The addition of proximal inflow
occlusion reduces blood leakage even with calcified
arteries. The tourniquet facilitates the operation, pro-
vides an environment for improved technical perfor-
mance, and can decrease certain segments of the over-
all operative time. The possibility also exists for fewer
early failures by preventing trauma to diseased or brit-
tle and calcified arteries that might otherwise occur
when standard vascular clamps are applied. Enzyme
changes that occur with the use of the tourniquet
have not correlated with clinical events, but these sub-
cellular findings require further study.
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